These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 32916298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
    Minh NV, Thanh NT, Lien HT, Anh DTP, Cuong HD, Nam NH, Hai PT, Minh-Ngoc L, Le-Thi-Thu H, Chinh LV, Vu TK.
    Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents.
    Hieu DT, Anh DT, Tuan NM, Hai PT, Huong LT, Kim J, Kang JS, Vu TK, Dung PTP, Han SB, Nam NH, Hoa ND.
    Bioorg Chem; 2018 Feb; 76():258-267. PubMed ID: 29223029
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
    Hieu DT, Anh DT, Hai PT, Huong LT, Park EJ, Choi JE, Kang JS, Dung PTP, Han SB, Nam NH.
    Chem Biodivers; 2018 Jun; 15(6):e1800027. PubMed ID: 29667768
    [Abstract] [Full Text] [Related]

  • 7. Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity.
    Huong TT, Dung DT, Huan NV, Cuong LV, Hai PT, Huong LT, Kim J, Kim YG, Han SB, Nam NH.
    Bioorg Chem; 2017 Apr; 71():160-169. PubMed ID: 28196602
    [Abstract] [Full Text] [Related]

  • 8. Novel 3-substituted-2-oxoindoline-based N-hydroxypropenamides as histone deacetylase inhibitors and antitumor agents.
    Dung do TM, Dung PT, Oanh DT, Hai PT, Huong le TT, Loi VD, Hahn H, Han BW, Kim J, Han SB, Nam NH.
    Med Chem; 2015 Apr; 11(8):725-35. PubMed ID: 26133355
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
    Hieu DT, Anh DT, Hai PT, Thuan NT, Huong LT, Park EJ, Young Ji A, Soon Kang J, Phuong Dung PT, Han SB, Nam NH.
    Chem Biodivers; 2019 Apr; 16(4):e1800502. PubMed ID: 30653817
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.
    Xie R, Yao Y, Tang P, Chen G, Liu X, Yun F, Cheng C, Wu X, Yuan Q.
    Eur J Med Chem; 2017 Jul 07; 134():1-12. PubMed ID: 28391133
    [Abstract] [Full Text] [Related]

  • 13. Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis.
    Dung DTM, Huan NV, Cam DM, Hieu DC, Hai PT, Huong LT, Kim J, Choi JE, Kang JS, Han SB, Nam NH.
    Med Chem; 2018 Jul 07; 14(8):831-850. PubMed ID: 29807520
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening.
    Liu J, Zhou J, He F, Gao L, Wen Y, Gao L, Wang P, Kang D, Hu L.
    Eur J Med Chem; 2020 Apr 15; 192():112189. PubMed ID: 32151834
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and evaluation of N-hydroxypropenamides based on adamantane to overcome resistance in NSCLC.
    Bao X, Sun Y, Bao C, Zhang J, Zou S, Yang J, Wu C, Wang L, Chen G.
    Bioorg Chem; 2019 May 15; 86():696-704. PubMed ID: 30831531
    [Abstract] [Full Text] [Related]

  • 16. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
    Cai J, Wei H, Hong KH, Wu X, Cao M, Zong X, Li L, Sun C, Chen J, Ji M.
    Eur J Med Chem; 2015 May 15; 96():1-13. PubMed ID: 25874326
    [Abstract] [Full Text] [Related]

  • 17. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT, Knoff JR, Pflum MKH.
    Eur J Med Chem; 2018 Jan 01; 143():1790-1806. PubMed ID: 29150330
    [Abstract] [Full Text] [Related]

  • 18. Structure-based design generated novel hydroxamic acid based preferential HDAC6 lead inhibitor with on-target cytotoxic activity against primary choroid plexus carcinoma.
    Kassab SE, Mowafy S, Alserw AM, Seliem JA, El-Naggar SM, Omar NN, Awad MM.
    J Enzyme Inhib Med Chem; 2019 Dec 01; 34(1):1062-1077. PubMed ID: 31072216
    [Abstract] [Full Text] [Related]

  • 19. Novel (E)-3-(3-Oxo-4-substituted-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-N-hydroxypropenamides as Histone Deacetylase Inhibitors: Design, Synthesis and Bioevaluation.
    Minh Sang D, Ho Na I, Tien Anh D, Thi Mai Dung D, Thi Thu Hang N, Phuong-Anh NT, Hai PT, Thi Kim Oanh D, Thanh Tung T, Jung Lee S, Hee Kwon J, Soon Kang J, Han SB, Thi Thanh Hai D, Nam NH.
    Chem Biodivers; 2023 May 01; 20(5):e202201030. PubMed ID: 37017259
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
    Cheng C, Yun F, He J, Ullah S, Yuan Q.
    Eur J Med Chem; 2019 Jul 01; 173():185-202. PubMed ID: 31003060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.